Simplified, Enhanced Protein Purification Using an Inducible, Autoprocessing Enzyme Tag

Department of Pathology, Stanford School of Medicine, Stanford, California, United States of America.
PLoS ONE (Impact Factor: 3.23). 12/2009; 4(12):e8119. DOI: 10.1371/journal.pone.0008119
Source: PubMed


We introduce a new method for purifying recombinant proteins expressed in bacteria using a highly specific, inducible, self-cleaving protease tag. This tag is comprised of the Vibrio cholerae MARTX toxin cysteine protease domain (CPD), an autoprocessing enzyme that cleaves exclusively after a leucine residue within the target protein-CPD junction. Importantly, V. cholerae CPD is specifically activated by inositol hexakisphosphate (InsP(6)), a eukaryotic-specific small molecule that is absent from the bacterial cytosol. As a result, when His(6)-tagged CPD is fused to the C-terminus of target proteins and expressed in Escherichia coli, the full-length fusion protein can be purified from bacterial lysates using metal ion affinity chromatography. Subsequent addition of InsP(6) to the immobilized fusion protein induces CPD-mediated cleavage at the target protein-CPD junction, releasing untagged target protein into the supernatant. This method condenses affinity chromatography and fusion tag cleavage into a single step, obviating the need for exogenous protease addition to remove the fusion tag(s) and increasing the efficiency of tag separation. Furthermore, in addition to being timesaving, versatile, and inexpensive, our results indicate that the CPD purification system can enhance the expression, integrity, and solubility of intractable proteins from diverse organisms.

Download full-text


Available from: Matthew Bogyo,
    • "Other protein linkers are induced by small molecules, e.g. thiol reagents, metal ions and small molecules like inositol hexakisphosphate (Chong et al., 1997, 1998b; Sadilkova et al., 2008; Shen et al., 2009). These inducers are mostly inexpensive and easy to remove from the target protein. "
    [Show abstract] [Hide abstract]
    ABSTRACT: For fast and easy purification, proteins are typically fused with an affinity tag, which often needs to be removed after purification. Here we present a method for the removal of the affinity tag from the target protein in a single step protocol. The protein VIC_001052 of the coral pathogen Vibrio coralliilyticus ATCC BAA-450 contains a metal ion-inducible autocatalytic cleavage (MIIA) domain. Its coding sequence was inserted into an expression vector for the production of recombinant fusion proteins. Following, the target proteins MalE and mCherry were produced as MIIA-Strep fusion proteins in E. coli. The target proteins could be separated from the MIIA-Strep part simply by the addition of calcium or manganese (II) ions within minutes. The cleavage is not affected in the pH range from 5.0 to 9.0 or at low temperatures (6° C). Autocleavage was also observed with immobilized protein on an affinity column. The protein yield was similar to that achieved with a conventional purification protocol. Copyright © 2015. Published by Elsevier B.V.
    Journal of Biotechnology 05/2015; 208. DOI:10.1016/j.jbiotec.2015.05.016 · 2.87 Impact Factor
  • Source
    • "The antimicrobial activity and toxicity of the Lucilin peptide is unknown. The Vibrio cholerae MARTX toxin cysteine protease domain (CPD) 1 is described as a self-cleavage tag that has been shown to enhance the expression, integrity and solubility of intractable proteins in Escherichia coli [8]. In this study, a recombinant analog of the Lucilin peptide fused to the CPD tag was produced in E. coli, purified by Nickel IMAC (immobilized metal affinity chromatography), and its antimicrobial activity assessed against a clinical isolated multidrug resistance E. coli strain. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lucilin is a 36 residue cecropin antimicrobial peptide identified as a partial genetic sequence in Lucilia sericata maggots. The antimicrobial spectrum and toxicity profile of Lucilin is unknown. We first report the expression of Lucilin as an active recombinant fusion protein with a cysteine protease domain (CPD) tag. The fusion protein, GWLK-Lucilin-CPD-His8, showed maximum overexpression in Escherichia coli BL21 cells after 12 hours induction with 0.5 mM IPTG (isopropyl beta-D-thiogalactoside) and growth conditions were 37 °C and 150 rpm shaking. The fusion protein was expressed as a soluble form and was purified by Ni-IMAC. The purified protein was active against E. coli ATCC 35218 with a MIC of 0.68 μM, and a clinical isolate of E. coli with extended spectrum beta-lactamase (ESBL) with a MIC of 0.8 μM. The recombinant GWLK-Lucilin-CPD-His8 was not toxic against human erythrocytes or Vero cells with a therapeutic index >63. The results suggest that GWLK-Lucilin-CPD-His8 represents a potential candidate for therapy against multidrug resistant Gram-negative bacteria.
    Protein Expression and Purification 05/2014; 100. DOI:10.1016/j.pep.2014.05.004 · 1.70 Impact Factor
  • Source
    • "So, we obtain PcrV and its various forms without a histidine tag for further downstream experiments. For detailed procedure refer Shen et al.[37]. ∆PcrV(159–294) had localized in the inclusion bodies. "
    [Show abstract] [Hide abstract]
    ABSTRACT: PcrV is a hydrophilic translocator of type three secretion system (TTSS) and a structural component of the functional translocon. C-terminal helix of PcrV is essential for its oligomerization at the needle tip. Conformational changes within PcrV regulate the effector translocation. PcrG is a cytoplasmic regulator of TTSS and forms a high affinity complex with PcrV. C-terminal residues of PcrG control the effector secretion.Result: Both PcrV and PcrG-PcrV complex exhibit elongated conformation like their close homologs LcrV and LcrG-LcrV complex. The homology model of PcrV depicts a dumbbell shaped structure with N and C-terminal globular domains. The grip of the dumbbell is formed by two long helices (helix-7 and 12), which show high level of conservation both structurally and evolutionary. PcrG specifically protects a region of PcrV extending from helix-12 to helix-7, and encompassing the C-terminal globular domain. This fragment [increment]PcrV(128-294) interacts with PcrG with high affinity, comparable to the wild type interaction. Deletion of N-terminal globular domain leads to the oligomerization of PcrV, but PcrG restores the monomeric state of PcrV by forming a heterodimeric complex. The N-terminal globular domain ([increment]PcrV(1-127)) does not interact with PcrG but maintains its monomeric state. Interaction affinities of various domains of PcrV with PcrG illustrates that helix-12 is the key mediator of PcrG-PcrV interaction, supported by helix-7. Bioinformatic analysis and study with our deletion mutant [increment]PcrG(13-72) revealed that the first predicted intramolecular coiled-coil domain of PcrG contains the PcrV interaction site. However, 12 N-terminal amino acids of PcrG play an indirect role in PcrG-PcrV interaction, as their deletion causes 40-fold reduction in binding affinity and changes the kinetic parameters of interaction. [increment]PcrG(13-72) fits within the groove formed between the two globular domains of PcrV, through hydrophobic interaction. PcrG interacts with PcrV through its intramolecular coiled-coil region and masks the domains responsible for oligomerization of PcrV at the needle tip. Also, PcrG could restore the monomeric state of oligomeric PcrV. Therefore, PcrG prevents the premature oligomerization of PcrV and maintains its functional state within the bacterial cytoplasm, which is a pre-requisite for formation of the functional translocon.
    BMC Structural Biology 01/2014; 14(1):5. DOI:10.1186/1472-6807-14-5 · 1.18 Impact Factor
Show more